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Introduction
Patients with heart failure accompanied by left ventricular (LV) systolic dysfunction (SHF) have significantly variable clinical courses. In patients with SHF, whose level of LV ejection fraction (EF) is insufficient to stratify the cardiac prognosis, LV diastolic function has been used for this purpose. In the clinical setting, Doppler transmitral flow (TMF) has been commonly used as a surrogate measure in assessing LV diastolic function [1] . Previous studies have shown that LV diastolic filling patterns by TMF provide additional information for stratification of the prognosis in patients with decompensated heart failure [2] [3] [4] [5] . In contrast, the plasma B-type natriuretic peptide (BNP) concentration is a reliable marker to diagnose both LV systolic dysfunction and congestive heart failure, as well as to stratify the prognosis of patients with SHF [6] [7] [8] [9] Previous studies have shown that LV diastolic function is a major determinant of plasma BNP concentration [10] [11] [12] . Thus, TMF and BNP have similar characteristics in assessment of the increasing of LV preload and prognosis in patients with SHF. Despite the interest in SHF management using Doppler echocardiography and plasma BNP concentration, clinical physicians may still be confused about the implications and meaning of the test results. With this in mind, the aim of this study was to determine the complementary and incremental value of a combination of Doppler echocardiographic examinations and plasma BNP concentration in stratification of the prognosis in patients diagnosed with decompensated SHF.
Methods

Study population
A total of 73 patients (58 men, 15 women; mean age 57 ± 15 years) who were admitted for SHF (EF <45%) were enrolled in this study. In all patients, Doppler echocardiographic examinations and measurements of the plasma BNP concentration were simultaneously performed before discharge. Patients with non-sinus rhythm, mitral stenosis, moderate to severe mitral regurgitation, moderate to severe aortic regurgitation, or poor technical quality of Doppler echocardiographic images were excluded from this study. Of 73 patients, 15 were excluded: 6 with loss of followup, 4 with atrial fibrillation, 3 without adequate echocardiographic images, 1 who had died of malignant lymphoma, and 1 who had died in a traffic accident; and 58 (44 men, 14 women; mean age 56 ± 14 years) were included in the study population.
Among these, 21 patients had ischemic heart disease and 27 non-ischemic dilated cardiomyopathy. Patients were followed up for 36 months after discharge. Primary end point for the follow-up was readmission for acute decompensated heart failure or cardiac death. This study was approved by the local research ethics committee, and the patients gave written informed consent.
Clinical risk factors
Multiple clinical and laboratory risk factors were determined, including presence of hypertension (systolic blood pressure >140 mmHg, diastolic blood pressure >90 mmHg, or treatment with antihypertensive agents); presence of hyperliplidemia (serum cholesterol >220 mg/dl or treatment with antihyperlipidemic agents); presence of diabetes mellitus (fasting glucose >125 mg/dl, hemoglobin A1c >6.4%, or treatment with antidiabetics).
Echocardiographic examination
All patients were examined in the left lateral position. Doppler and M-mode echocardiographic data were obtained with an echocardiographic system (SSA 390A, Toshiba Medical, Tokyo, Japan) equipped with a multifrequency transducer, at a sweep speed of 100 mm/s. Images were recorded on super-VHS video and then exported to a computer workstation (UIWS-300A, Toshiba Medical) for offline analysis. The pulsed Doppler TMF was recorded from the apical long-axis view, with a pulsed-wave Doppler sample volume placed at the tip of the mitral valve leaflets. From the TMF, peak velocity of early wave (E), peak velocity of late wave at the atrial contraction (A), the ratio of E to A (E/A), deceleration time of the early wave (DT), and duration of the late wave (Ad) were measured. A pulsed Doppler pulmonary venous flow was obtained with a contrast echocardiographic examination. Pulmonary venous flow was obtained with the sample volume placed 5-10 mm from the junction of the left atrium and the right upper pulmonary vein. The duration of the reversal wave during atrial contraction (PVAd) was determined. Color Doppler propagation velocity (Vp) was measured by an aliasing velocity level based on the E of the TMF [13] . TMF patterns were classified into 4 types: normal pattern, 1.0 E/A < 2.0, 160 < DT < 240 ms, and (PVAd-Ad)<0 ms; abnormal relaxation pattern, E/A <1.0; pseudonormal pattern, 1.0 E/A <2.0, 160 DecT <200 ms, and (PVAd-Ad) ≥0 ms; and restrictive filling pattern, E/A ≥2.0 and DecT <160 ms, and (PVAd-Ad) ≥0 ms [14] . The ratio of E to Vp (E/Vp) was measured as an index for LV filling pressure [15] . All Doppler echocardiographic variables were represented as the mean values calculated for 3-consecutive cardiac cycles. LV end-diastolic volume, LV end-systolic volume, and LVEF were measured using a modified Simpson's method.
Measurements of plasma BNP concentration
Blood was drawn into tubes containing ethylenediaminetetraacetic acid (1 mg/ml) and aprotinin (500 U/ml) from a peripheral vein for BNP measurements during the echocardiographic study. These blood samples were chilled with ice and immediately centrifuged at 3000 rpm for 10 min at 4 • C, then stored at −80 • C until analysis. Plasma BNP concentration was measured by immunoradiometric assay (Shionogi & Co. Ltd., Osaka, Japan), with reference values of less than 20 pg/ml.
Statistical analysis
Data are expressed as the mean value ± S.D. Student's unpaired t test was performed to compare continuous values, and chi-square test for categorical variables between the two groups. Logtransformed values for BNP (log BNP) were used in these analyses to reduce the effects of skewed distribution of BNP values. Correlations with log BNP were evaluated by simple linear regression analysis. A stepwise multilinear regression on the estimation of log BNP was then performed. Receiver operating characteristic (ROC) curves were constructed to determine optimal sensitivity and specificity. Cardiac event-free survival curves were estimated using the Kaplan-Meier method, and survival curves were compared by log-rank test. Univariate Cox proportional hazards analysis was used to adjust for time-to-event. A multivariate Cox proportional hazards model with a stepwise selection procedure was applied to identify an independent predictor among significant predictors of primary endpoints. p < 0.05 was considered to indicate statistical significance. Dr. SPSS II for Windows statistical program (SPSS Inc., Chicago, IL, USA) was used for ROC curve analysis. Remaining analyses were performed using Stat View software (J-5.0, Abacus, Berkeley, CA, USA).
Results
All non-readmitted patients were followed up to 36 months after discharge. During the mean followup period of 28 ± 12 months, 16 patients (27.6%) were readmitted with acute decompensated heart failure and 6 (10.3%) suffered cardiac death during their re-hospitalization. Comparisons of clinical characteristics between patients with and without re-hospitalization are summarized in Table 1 . Diuretics were more prevalent in re-hospitalized patients, but other characteristics did not differ between groups. Doppler echocardiographic data are summarized in Table 2 . In readmitted patients, E was higher, A was lower, thereby making E/A higher, and DT was shorter as compared with those in non-readmitted patients. In addition, PVAd, (PVAd-Ad), and E/Vp in readmitted patients were higher than those in non-readmitted patients.
TMF patterns were classified into abnormal relaxation pattern in 27 patients (46.6%), pseudonormal pattern in 19 (32.8%), and restrictive filling pattern in 12 (20.7%). Of the patients, 2 (7.4%) with abnormal relaxation pattern, 6 (31.5%) with pseudonormal pattern, and 8 (66.7%) with restrictive filling pattern were readmitted. Fig. 1 shows that event-free survival rates were significantly lower in patients with pseudonormal (p = 0.02) or restrictive filling pattern (p < 0.001), than in those with abnormal relaxation pattern. However, event-free survival rates did not differ between patients with pseudonormal pattern and those with restrictive filling pattern (p = 0.09).
In addition, based on ROC analysis, E/A ≥1.05 (AUC = 0.836, p = 0.002) was identified as the optimal cutoff point to predict the primary end point.
Plasma BNP concentrations were significantly higher in readmitted patients, compared with those who were not readmitted (316 ± 268 pg/ml vs. 142 ± 225 pg/ml, p = 0.01). Plasma BNP concentrations (log BNP) were significantly correlated with Doppler echocardiographic variables (Table 3) . In a stepwise multiple linear regression analysis, E/Vp and (PVAd-Ad) were identified as the best variables in estimating log BNP level (r = 0.49, p < 0.001, beta coefficient E/Vp = 0.27, PVAd-Ad = 0.35). Based on ROC analysis, plasma BNP concentration ≥254.5 pg/ml (AUC = 0.768, p = 0.002) was identi- fied as the optimal cutoff point to predict the primary end point. Event-free survival rates were significantly lower in patients with plasma BNP concentration ≥254.5 pg/ml as compared to those with plasma BNP concentration < 254.5 pg/ml (28.6% vs. 85.0%, p < 0.001).
Univariate predictors of the primary endpoint as analyzed by Cox proportional hazards model are summarized in Table 4 . Based on the stepwise analysis, E/A (chi-square = 6.5, relative risk
[RR] = 1.66, p = 0.01) as correlated with plasma BNP concentration (chi-square = 3.9, RR = 1.70, p = 0.04) was identified as an independent predictor among significant predictors of primary endpoints. In addition, patients with E/A ≥1 were classified into 2 groups based on the plasma BNP concentration: Group I, BNP < 254.5 ng/l (19 patients); Group II, BNP ≥254.5 (12 patients). Fig. 2 shows that eventfree survival rates were significantly lower in Group II (p < 0.001). 
Discussion
We have shown that combined assessments based on Doppler TMF and plasma BNP concentration at predischarge may be useful in the risk stratification and follow-up of patients with SHF. A feature of the present study is the relatively longer followup period (36 months), as compared with those in previous studies (6 months to 24 months), which compared prognostic efficacy between Doppler echocardiography and plasma BNP concentration [9, 16, 17] . This study suggests that the combined stratification at predischarge may be used as a sur- 
Doppler-derived indexes and CHF prognosis
In the present study, the E/A ratio was identified as an independent predictor for the prognosis based on cardiac events. Previous studies have shown a relationship between the restrictive fill- ing pattern characterized by higher E/A ratio and short DT and poor mortality prognosis in patients with heart failure [2] [3] [4] [5] . The present study has additionally shown that the pseudonormal pattern may provide similar information about the prognosis of patients with SHF, and the approximate optimal level of the E/A ratio to stratify the endpoint was close to 1.0. Whalley et al. [4] have shown that patients with congestive heart failure and pseudonormal pattern had poor prognosis, similar to those with restrictive filling pattern, and Møller et al. [18] also have shown that patients with acute myocardial infarction and pseudonormal pattern had poor prognosis, also similar to those with restrictive filling pattern. In general, differentiation between normal pattern and pseudonormal pattern has been a clinical issue regarding the use of TMF in identifying diastolic filling abnormalities [1] ; however, on the basis that LV diastolic dysfunction is accompanied by systolic dysfunction, TMF patterns progress from an abnormal relaxation pattern to a pseudonormal pattern and then finally to a restrictive filling pattern, depending on the preload [19] . Therefore, an increase of E/A ratio commonly indicates progression of diastolic dysfunction in patients with SHF. In contrast, the present study has shown that other Doppler indexes (DT, E/Vp, PVAdAd) are also associated with the prognosis of our patients, as previous studies have shown relationships between these indexes and the prognosis in patients with cardiac disease [3, 18, 20] . In patients with LV systolic dysfunction, the indexes derived from Doppler TMF are strongly correlated with LV filling pressure [21, 22] . As LV systolic dysfunction was a basic criterion for selection of subjects in this study, the E/A ratio may be identified as the best predictive Doppler index. In previous studies, the important independent predictors derived from Doppler echocardiography vary depending upon the study cited, as follows: DT [3] , E/Vp [18] , (PVAd-Ad) [20] , and the ratio of E to tissue Doppler early diastolic mitral annular velocity (E/E ) [16] . Inspection reveals an index to estimate LV filling pressure is in common to these indexes, and therefore reliably detecting the presence of increased LV filling pressure may provide additional information useful to the stratification of prognosis in patients with SHF.
The role of plasma BNP concentration
In comparison to the E/A ratio, we could not show the superiority of plasma BNP concentration in the first step stratification at predischarge. In previous studies comparing the prognostic efficacy between Doppler echocardiography and plasma BNP concentration, the superiority has been controversial: only plasma BNP concentration was correlated with the prognosis [9, 17] ; in contrast, Doppler index (E/E ) and plasma BNP concentration were incrementally correlated with prognosis in patients with heart failure [16] . Plasma BNP concentration and Doppler TMF have similar determinants associated with LV diastolic properties [1, [10] [11] [12] 19] . In the present study, plasma BNP concentration was also correlated with diastolic Doppler indexes; however, plasma BNP concentrations are affected by other various factors: age, RV dysfunction, severity of mitral regurgitation, renal function, and LV hypertrophy, in addition to diastolic function [23, 24] . The complex determinants of BNP may explain the weak correlations with LV filling pressure in patients admitted to the intensive care unit [24, 25] , and may also explain the lack of specificity in detecting the prognosis of patients with LV systolic dysfunction in comparison to the E/A ratio. In contrast, the present study has shown that the plasma BNP concentration has a strong predictive value for readmission in patients with pseudonormal or restrictive filling pattern. Logeart et al. [26] showed that TMF patterns are more accurate in diagnosis of congestive heart failure in patients with intermediate plasma BNP concentration (80-300 pg/ml); in contrast, higher plasma BNP concentrations (>300 pg/ml) have similar accuracy to that of TMF patterns. As discussed above, plasma BNP concentration determinants such as renal dysfunction and mitral regurgitation may complicate the correlations between plasma BNP concentration and the diagnosis of heart failure. In contrast, mitral regurgitation, RV overload, and renal dysfunction have been independent features of the mortality in patients with heart failure [27] [28] [29] . Therefore, plasma BNP concentration relating such factors may have additional value to stratify the risk of readmission in patients in the setting of high risk based on the TMF.
Clinical implications
We suggest a clinical algorithm for stratification of patients with SHF (Fig. 3) . As a first step, the E/A ratio at predischarge should be used as a surrogate measure in predicting prognosis of patients with SHF. In patients with E/A ratio ≥1.0, plasma BNP concentration ≥254 pg/ml is a strong predictive indicator for readmission, and may be an optimal target to determine the need for other interventions. In contrast, an E/A ratio <1.0 after treatments is the strongest predictor of good outcome under optimal medication. 
Study limitations
First, the study population might not have been large enough to determine our suggestion. Therefore, in the future, studies comprising larger numbers of patients are needed. However, in spite of the relatively small number of patients, the optimal cutoff value of plasma BNP concentration in predicting cardiac events as found (about 250 pg/ml) was close to those in previous studies with larger numbers of subjects [17, 18] . Second, since patients with atrial fibrillation or severe valvular disease were excluded, the results of our study should not be extrapolated to such populations.
Conclusions
In patients with SHF, the E/A ratio may be the first measure to use as a predicator for the prognosis. In patients with higher E/A ratio (≥1.0), plasma BNP concentration may provide the incremental information to stratify the risk of readmission as the second measure. Thus, the complementary assessment of Doppler TMF and plasma BNP concentration may be reliable in identifying the prognosis of patients with SHF, and determining the optimal target for treatments.
